MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?

Meeting abstracts - A single PDF containing all abstracts in this supplement is available at http://www.biomedcentral.com/content/files/pdf/1546-0096-9-S1-full.pdf.EMPTY Background In recent years, MRI and US have been increasingly used as outcome measures in clinical trials in rheumatoid arthritis;...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric Rheumatology 2011-09, Vol.9 (S1), p.O12-O12, Article O12
Main Authors: Malattia, C, Consolaro, A, Pederzoli, S, Damasio, MB, Hasija, R, Mazzoni, M, Madeo, A, Beltramo, A, Viola, S, Buoncompagni, A, Mattiuz, C, Ravelli, A, Martini, A
Format: Article
Language:English
Subjects:
Arthritis
Clinical trials
Oral Presentation
Pediatrics
Rheumatology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Meeting abstracts - A single PDF containing all abstracts in this supplement is available at http://www.biomedcentral.com/content/files/pdf/1546-0096-9-S1-full.pdf.EMPTY Background In recent years, MRI and US have been increasingly used as outcome measures in clinical trials in rheumatoid arthritis; their value in evaluating treatment efficacy has never been tested in juvenile idiopathic arthritis (JIA).
ISSN:1546-0096
1546-0096
DOI:10.1186/1546-0096-9-S1-O12